関連する実験動画
Updated: Jul 5, 2026
06:22
Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
1型糖尿病,高血糖症,心臓病などがあります
Ravi Retnakaran1, Bernard Zinman
1Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto, Canada.
Lancet (London, England)
|May 27, 2008
まとめ
1型糖尿病は,心血管疾患のリスクを大幅に高めます. 集中治療を通じて血糖 (高血糖) を管理することは,これらの患者の心臓合併症を減らすために非常に重要です.
科学分野:
- 心臓病学 心臓病学
- エンドクリノロジー エンドクリノロジー
- メタボリック疾患
背景:
- 1型糖尿病 (T1D) は,心血管疾患 (CVD) のリスクを高め,患者の年齢のためにしばしば見過ごされます.
- 糖尿病の心臓は,加速性動脈硬化症,心臓の自律神経症,および内在性心筋症など,複数の脅威に直面しています.
研究 の 目的:
- T1Dが心臓に及ぼす影響に関する現在の理解をレビューする.
- T1DにおけるCVDリスクを媒介するハイパーグリセミアの中心的な役割を強調する.
- 糖尿病の集中管理が心血管疾患に与える効果を強調する.
主な方法:
- 既存の文献と臨床試験データのレビュー.
- 糖尿病制御および合併症試験/糖尿病介入および合併症の流行病学 (DCCT/EDIC) の発見に焦点を当てます.
- T1Dにおける高血糖症と心血管合併症の関係に関する分析.
主要な成果:
- ハイパーグリセミアは,T1Dにおける心臓血管リスクの有意なメディエーターとして確認されています.
- 糖尿病の集中治療は,心血管疾患のアウトカムを明らかに軽減します.
- T1Dにおける高血糖症とCVDとの関連は,今や決定的に確立されています.
結論:
- ハイパーグリセミアは,タイプ1糖尿病における心血管疾患のリスクを高めることに中心的な役割を果たします.
- 熱心な血糖コントロールは,T1D患者の心血管合併症を軽減するために不可欠です.
- これらのメカニズムを理解することは,T1Dにおける長期的な心血管の健康を改善するための鍵です.
関連する概念動画
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...